These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 810634)

  • 21. [Study of Iskedyl in otoneurologic ischemia].
    Duchamps B
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Sep; 23(7):649-53. PubMed ID: 4280429
    [No Abstract]   [Full Text] [Related]  

  • 22. [Eutergine and retinal arteriosclerosis].
    Ourgaud AG; Metge P; Cazenave P
    Bull Soc Ophtalmol Fr; 1975; 75(5-6):591-607. PubMed ID: 813835
    [No Abstract]   [Full Text] [Related]  

  • 23. [Intravenous infusions in the treatment of arterial occlusive diseases from the surgical point of view].
    Hugeneck J
    Wien Med Wochenschr; 1976 Sep; 126(38):542-4. PubMed ID: 788353
    [No Abstract]   [Full Text] [Related]  

  • 24. [Electroencephalographic findings in cerebral vascular diseases in aged patients and their changes under the influence of sympatholytic (Hydergine) therapy].
    Kauchtschischwili GM; Pontiggia M; Zerbi F
    Riv Neurol; 1967; 37(3):231-50. PubMed ID: 4965103
    [No Abstract]   [Full Text] [Related]  

  • 25. [The vasoactivogram in the treatment of peripheral arteriopathies].
    Romeo S; Spinella G; Sciacchitanto D
    Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
    [No Abstract]   [Full Text] [Related]  

  • 26. Dihydrogenated alkaloids of ergot in geriatric patients: symptomatic treatment of cerebrovascular insufficiency.
    Kaye C
    Bol Asoc Med P R; 1972 Nov; 64(11):301-3. PubMed ID: 4205800
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of hydergine on the functional manifestations of encephalic vasomotricity].
    Memin Y; Rigal P
    Lyon Med; 1971 Jun; 225(11):1177-82. PubMed ID: 4997290
    [No Abstract]   [Full Text] [Related]  

  • 28. [Arterial hypertension in gravidity and the authors' experience with Crystepin therapy (author's transl)].
    Baková O; Blekta M; Zivný J
    Cesk Gynekol; 1976 Apr; 41(2):112-3. PubMed ID: 817804
    [No Abstract]   [Full Text] [Related]  

  • 29. Sinus bradycardia following treatment with hydergine for cerebrovascular insufficiency.
    Dcayley AC; Macpherson A; Wedgwood J
    Br Med J; 1975 Nov; 4(5993):384-5. PubMed ID: 811310
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prevention of thromboembolism in meniscus surgery using Panthesin-Hydergin].
    Nawaz AW
    Med Monatsschr; 1974 Dec; 28(12):542-4. PubMed ID: 4375788
    [No Abstract]   [Full Text] [Related]  

  • 31. [On treatment of acute cerebrovascular accidents].
    Berselli L; Ferracini R
    Clinica; 1965 Sep; 25(1):68-75. PubMed ID: 4954699
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical experiences with the vascular action of dihydroergocristine].
    Tomasi AM; Baggioni GF; Pozzar C
    Minerva Cardioangiol; 1975 Jan; 23(1):7-19. PubMed ID: 806854
    [No Abstract]   [Full Text] [Related]  

  • 33. Symptomatic treatment of cerebrovascular insufficiency with hydergine.
    Gerin J
    Curr Ther Res Clin Exp; 1969 Sep; 11(9):539-46. PubMed ID: 4980884
    [No Abstract]   [Full Text] [Related]  

  • 34. Dihydrogenated ergot alkaloids (Hydergine) and cerebrovascular insufficiency.
    Med Lett Drugs Ther; 1970 Mar; 12(6):27-8. PubMed ID: 4994841
    [No Abstract]   [Full Text] [Related]  

  • 35. Relieving select symptoms of the elderly.
    Nelson JJ
    Geriatrics; 1975 Mar; 30(3):133-9, 142. PubMed ID: 803912
    [No Abstract]   [Full Text] [Related]  

  • 36. [Determinants estimating cerebral functions after long term therapy with hydergin].
    Herzfeld U; Christian W; Ronge J; Wittgen M
    Arztl Forsch; 1972 Jun; 26(6):215-28. PubMed ID: 4626216
    [No Abstract]   [Full Text] [Related]  

  • 37. [Electroencephalographic and clinical study of the action of hydrogen derivatives of Ergotoxin].
    Borenstein P; Cujo P; Bahon L
    Ann Med Psychol (Paris); 1969 Oct; 2(3):410-24. PubMed ID: 4983442
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prevention of drepanocytic painful crises with hydergine].
    Cuisinier JC; Ducloux M; Lagarde B; Barbotin M; Darracq R
    Bull Soc Med Afr Noire Lang Fr; 1974; 19(2):168-72. PubMed ID: 4219596
    [No Abstract]   [Full Text] [Related]  

  • 39. [Attempt at psychometric evaluation of aging: study of a vascular drug].
    Losson M; Losson JP
    Therapeutique; 1969 Mar; 45(3):313-7. PubMed ID: 4989246
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of cerebrovascular processes and their reactions to pharmacotherapy by means of ultrasonic methods.
    Klein K; Klein M; Klein P
    Z Alternsforsch; 1985; 40(6):369-74. PubMed ID: 2934900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.